Analyze Diet
Acta veterinaria Scandinavica1997; 38(1); 17-27; doi: 10.1186/BF03548504

Gelatinolytic activity in tracheal aspirates of horses with chronic obstructive pulmonary disease.

Abstract: The gelatinolytic activity in tracheal aspirates (TA) of horses with chronic obstructive pulmonary disease (COPD) was analyzed using SDS-PAGE-gelatin-gel electrophoresis (zymography) and compared to TAs from healthy controls. The 110-90 kD MMP-9 type gelatinase was high in symptomatic disease phases (permanent disease 0.46 +/- 0.15, p < 0.001; or intermittent disease 0.47 +/- 0.12, p < 0.001) compared to healthy controls (0.10 +/- 0.07). Similarly, the overall gelatinolytic activity, the activity in high-mw gelatinolytic bands (210-190 and 150 kD) and in proteolytically processed fragments in the 50-40 kD range were high, whereas the 75-65 kD MMP-2 was not altered. These findings suggest that MMP-9 type gelatinases, originating possibly from neutrophils or macrophages, and products thereof have a role in the pathogenesis of equine respiratory diseases, whereas MMP-2 type gelatinases represent house-keeping proteinases involved with normal tissue remodelling. The gelatinolytic activity in TAs correlated with the beta-glucuronidase activity, which indicates that they are simultaneously elevated in the respiratory secretions of horses suffering from COPD and might both be of same origin, or have a causal relationship.
Publication Date: 1997-01-01 PubMed ID: 9129343PubMed Central: PMC8057023DOI: 10.1186/BF03548504Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on the study of gelatinolytic activity in the tracheal aspirates (TA) of horses affected with chronic obstructive pulmonary disease (COPD) and comparing it with the TA from healthy horses. The results indicate higher activity of MMP-9 type gelatinases and overall gelatinolytic activity in horses with COPD than in healthy ones.

About the Study

  • This research utilized an analytical procedure called SDS-PAGE-gelatin-gel electrophoresis (zymography) to analyze the gelatinolytic activity in TAs of horses with COPD. Gelatinolytic enzymes are enzymes that break down gelatin, a derivative of collagen, which is a major component of the extracellular matrix in animal tissues.
  • The researchers used horses suffering from two different types of COPD – permanent and intermittent – and compared the results with healthy controls. Gelatinolytic activity was found to be higher in COPD-affected horses, specifically MMP-9 type gelatinase was presented in high amounts.

Main Findings

  • The researchers discovered that the gelatinases, particularly the 110-90 kD MMP-9 type, had high activity in symptomatic disease phases of COPD. The MMP-9 type gelatinase levels were significantly higher in COPD-affected horses compared with healthy controls.
  • The overall gelatinolytic activity was also higher in COPD-affected horses, as well as the activity in high-molecular-weight gelatinolytic bands and proteolytically processed fragments in the 50-40 kD range. However, the 75-65 kD MMP-2 gelatinase was not altered, indicating that this type is associated mainly with normal tissue remodelling.
  • These findings suggest that MMP-9 type gelatinases, possibly originating from neutrophils or macrophages, and their products, play a crucial role in the pathogenesis of equine respiratory diseases like COPD.
  • In addition, the researchers found a correlation between the gelatinolytic activity in TAs and the beta-glucuronidase activity, suggesting that the two are simultaneously increased in the respiratory secretions of horses with COPD. This could indicate a common origin or a causal relationship between the two activities.

Implications

  • This study provides crucial insights into the role of gelatinolytic activity in equine COPD. Enhanced understanding of the role of different gelatinases, especially MMP-9 type, in COPD may pave the way for new therapeutic strategies to treat the disease.
  • The correlation between gelatinolytic activity and beta-glucuronidase activity also sheds light on the possible mechanisms involved in the pathogenesis of COPD. However, more detailed studies will be needed to fully understand how these two activities are related and their exact roles in disease development.

Cite This Article

APA
Koivunen AL, Maisi P, Konttinen YT, Sandholm M. (1997). Gelatinolytic activity in tracheal aspirates of horses with chronic obstructive pulmonary disease. Acta Vet Scand, 38(1), 17-27. https://doi.org/10.1186/BF03548504

Publication

ISSN: 0044-605X
NlmUniqueID: 0370400
Country: England
Language: English
Volume: 38
Issue: 1
Pages: 17-27

Researcher Affiliations

Koivunen, A L
  • Department of Clinical Veterinary Sciences, Faculty of Veterinary Medicine, University of Helsinki, Finland.
Maisi, P
    Konttinen, Y T
      Sandholm, M

        MeSH Terms

        • Animals
        • Collagenases / metabolism
        • Gelatin / metabolism
        • Gelatinases / isolation & purification
        • Gelatinases / metabolism
        • Glucuronidase / metabolism
        • Horse Diseases
        • Horses
        • Lung Diseases, Obstructive / enzymology
        • Lung Diseases, Obstructive / veterinary
        • Matrix Metalloproteinase 2
        • Matrix Metalloproteinase 9
        • Metalloendopeptidases / metabolism
        • Mucous Membrane / enzymology
        • Suction
        • Trachea

        References

        This article includes 39 references
        1. Beech J. Tracheobronchial aspirates. In: J B, editor. Equine respiratory disorders. Philadelphia, USA: Lea and Febiger; 1991. pp. 41–53.
        2. Burrell MH. Endoscopic and virological observations on respiratory disease in a group of young Thoroughbred horses in training. Equine vet. J. 1985;17:99–103.
        3. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI, Welgus HG. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol. 1991;146:1286–1293.
          pubmed: 1991967
        4. Campbell EJ, Senior RM, Welgus HG. Extracellular- matrix injury during lung inflammation. Chest 1987;92:161–167.
          doi: 10.1378/chest.92.1.161pubmed: 3036424google scholar: lookup
        5. Clarke AF. Chronic pulmonary disease - A multifaceted disease complex in the horse. Ir. vet. J. 1987;41:258–264.
        6. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Selzer JL, Kronberger AHC, Bauer EA, Goldberg GI. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 1988;263:6579–6587.
          pubmed: 2834383
        7. Deegen E. Das chronisch lungenkranke Pferd und sein Einsatz im Sport. (Horse with a chronic lung disease and its input in sport.). Praktische Tier- artz. 1987;65:15–19.
        8. Deegen E, Klein H-K. Interpleural pressure measurement and bronchial spasmolysis tests in the horse performed with transportable oesophageal pressure measuring instrument. Pferdeheilkunde 1987;3:213–221.
          doi: 10.21836/PEM19870404google scholar: lookup
        9. Derksen FJ. Chronic obstructive pulmonary disease. In: J B, editor. Equine respiratory disorders. Philadelphia, USA: Lea & Febiger; 1991. pp. 223–235.
        10. Derksen F, Arthur RM, Dillon G, Pascoe J, Sweeney C. A round table discussion on chronic obstructive pulmonary disease (COPD). Equine Practice 1991;73:25–28.
        11. Desrivieres S, Lu H, Peyri N, Soria C, Legrand Y, Menashi S. Activation of the 92 kDa type IV collagenase by tissue kallikrein. J. Cell. Physiol. 1993;157:587–593.
          doi: 10.1002/jcp.1041570319pubmed: 8253870google scholar: lookup
        12. Garbisa S, Ballin M, Daga-Gordini D, Fastelli G, Naturale M, Negro A, Semenzato G, Liotta LA. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J. Biol. Chem. 1986;261:2369–2375.
          pubmed: 3003112
        13. Griinig G. Proteaseaktivitat im Tracheobronchial- sekret von Pferden mit COPD: Pathophysiologi- sche Bedeutung. (Protease activity in tracheobronchial secretions of horses with COPD and its relevance for pathogenesis.). Pferdeheilkunde 1985;7:55–63.
          doi: 10.21836/PEM19850106google scholar: lookup
        14. Guttmann I, Bergmeyer HU. Determination of urea with glutamate dehydrogenase as indicator enzyme. In: HU B, editor. Methods of enzymatic analysis. 2nd ed. New York: Academic Press; 1974. pp. 1794–1798.
        15. Hibbs DS, Hembry RM, Docherty APJ, Reynolds JJ. Purification and characterization of human 72- kDa gelatinase (type IV collagenase). Use of immunolocalization to demonstrate the noncoordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol. Chem. Hoppe-Seyler 1991;372:287–296.
          pubmed: 1647782
        16. Hibbs MS, Hoidal JR, Kang AH. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J. Clin. Invest. 1987;80:1644–1650.
          doi: 10.1172/JCI113253pmc: PMC442435pubmed: 3680518google scholar: lookup
        17. Kalebic T, Garbisa S, Glaser B, Liotta LA. Basement membrane collagen: Degradation by migrating endothelial cells. Science 1983;227:281–283.
          doi: 10.1126/science.6190230pubmed: 6190230google scholar: lookup
        18. Koivunen A-L, Maisi P, Fang W, Sandholm M. Inhibition of the protease activity in tracheobronchial aspirates of horses with COPD. Amer. J. vet. Res. 1996;57:603–607.
          pubmed: 8723867
        19. Koj A, Chudnik J, Dubin A. Substrate specificity and modification of the active center of elastase-like neutral proteinases from horse blood leucocytes. Biochem. J. 1976;753:397–402.
          doi: 10.1042/bj1530397pmc: PMC1172585pubmed: 6009google scholar: lookup
        20. Kolodny EH, Mumford RA. Human leucocyte acid hydrolases: Characterization of eleven lysosomal enzymes and study of reaction conditions for their automated analysis. Clin. Chim. Acta. 1976;70:247–257.
          doi: 10.1016/0009-8981(76)90426-5pubmed: 8226google scholar: lookup
        21. Konttinen YT, Lindy O, Suomalainen K, Ritchlin C, Saari H, Vauhkonen M, Lauhio A, Santavirta S, Sorsa T. Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix 1991;77:395–403.
          doi: 10.1016/S0934-8832(11)80194-0pubmed: 1664909google scholar: lookup
        22. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Production of matrix metalloproteinase 2 (gelatinase/ type IV collagenase) and 3 (stromelysin) by cultured oral squamous cell carcinoma. J. Oral Pathol. 1992;21:221–224.
        23. Lauhio A, Konttinen YT, Tschesche H, Nordstrdm D, Salo T, Lahdevirta J, Golub LM, Sorsa T. Reduction of matrix metalloproteinase-8 levels during long-term doxycycline treatment. Antimicrob. Agents and Chemother. 1994;38:400–402.
          doi: 10.1128/AAC.38.2.400pmc: PMC284468pubmed: 8192476google scholar: lookup
        24. Lauhio A, Salo T, Ding Y, Konttinen YT, Nordstrdm D, Tschesche H, Lahdevirta J, Golub LM, Sorsa T. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and NS AID in acute reactive arthritis. Clin. Exp. Immunol. 1994;98:21–28.
        25. MacNamara B, Bauer S, Iafe J. Endoscopic evaluation of exercise-induced pulmonary haemorrhage and chronic obstructive pulmonary disease in association with poor performance in racing Standardbreds. J. Amer. vet. med. Assoc. 1990;196:443–445.
          pubmed: 2298674
        26. Mainardi CL, Pourmotable TF, Hasty KA. Inflammatory phagocytes and connective tissue degrading metalloproteinases. Amer. J. med. Sci. 1991;302:171–175.
        27. Maisi P, Koivunen A-L, Rantala A-R, Turgut K. 3- glucuronidase and trypsin inhibitor capacity of tracheal lavage fluid as indicators of seasonal airway irritation in the horse. Equine vet. J. 1994;26:385–391.
        28. Moore BR, Krakowka S, Robertson JT, Cummings JM. Cytologic evaluation of bronchoalveolar lavage fluid obtained from Standardbred racehorses with inflammatory airway disease. Amer. J. vet. Res. 1995;56:562–567.
          pubmed: 7661448
        29. Rennard S, Basset G, Lecossier D, Donnel K, Martin P, Crystal RG. Estimation of volume of epithelial lining fluid recovered by lavage by using urea as a marker of dilution. J. Appl. Physiol. 1986;60:532–538.
          doi: 10.1152/jappl.1986.60.2.532pubmed: 3512509google scholar: lookup
        30. Rossdale PD, Hopes R, Wingfield Digby NJ, Offord K. Epidemiological study of wastage among racehorses 1982 and 1983. Vet. Rec. 1985;116:66–69.
          doi: 10.1136/vr.116.3.66pubmed: 3976145google scholar: lookup
        31. Saari H, Suomalainen K, Lindy O, Konttinen YT, Sorsa T. Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases. Biochem. Biophys. Res. Com- mun. 1990;171:979–987.
          doi: 10.1016/0006-291X(90)90780-Qpubmed: 2171513google scholar: lookup
        32. Sandholm M, Jdrvinen M, Halonen S, Eriksson A, Nyholm K, Maisi P. Enzymology of tracheal lavage fluid in horses with bronchial hyperreactivity. In: Proceedings of the International Society for Animal Clinical Biochemistry. Ed: J.J. Kaneko, Davis, California, USA 1990, pp. 51–157.
        33. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92- and 72-kilodal- ton type IV collagenases are elastases. J. Biol. Chem. 1991;266:7870–7875.
          pubmed: 1850424
        34. Sepper R, Konttinen YT, Sorsa T, Koski H. Gelatino- lytic and type IV collagenolytic activity in bronchiectasis disease. Chest 1994;106:1129–1133.
          doi: 10.1378/chest.106.4.1129pubmed: 7924484google scholar: lookup
        35. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 1990;141:471–501.
          doi: 10.1164/ajrccm/141.2.471pubmed: 2405761google scholar: lookup
        36. Stockley RA. Proteolytic enzymes, their inhibitors and lung diseases. Clinical Science 1983;64:119–126.
          doi: 10.1042/cs0640119pubmed: 6185266google scholar: lookup
        37. Van den Ingh TSGAM. Morphological aspects of bronchitis and bronchiolitis in the horse. In: Deegen E, Beadle RE. Hippiatrika (eds.): Proceedings of the international symposium of lung function and respiratory diseases in the horse. Germany. 1985, pp. 13–15.
        38. Weiss SJ. Tissue destruction by neutrophils. New Engl. J. Med. 1989;320:365–376.
          pubmed: 2536474
        39. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 1991;5:2145–2154.
          doi: 10.1096/fasebj.5.8.1850705pubmed: 1850705google scholar: lookup

        Citations

        This article has been cited 8 times.
        1. Davis KU, Sheats MK. Differential gene expression and Ingenuity Pathway Analysis of bronchoalveolar lavage cells from horses with mild/moderate neutrophilic or mastocytic inflammation on BAL cytology. Vet Immunol Immunopathol 2021 Apr;234:110195.
          doi: 10.1016/j.vetimm.2021.110195pubmed: 33588285google scholar: lookup
        2. Barton AK, Shety T, Klier J, Geis S, Einspanier R, Gehlen H. Metalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma. Mediators Inflamm 2019;2019:7845623.
          doi: 10.1155/2019/7845623pubmed: 31316303google scholar: lookup
        3. Barton AK, Gehlen H. Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?. Mediators Inflamm 2016;2016:5693205.
          doi: 10.1155/2016/5693205pubmed: 28053371google scholar: lookup
        4. Barton AK, Shety T, Bondzio A, Einspanier R, Gehlen H. Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction. BMC Vet Res 2016 Dec 9;12(1):282.
          doi: 10.1186/s12917-016-0915-1pubmed: 27938355google scholar: lookup
        5. Barton AK, Shety T, Bondzio A, Einspanier R, Gehlen H. Metalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse. Mediators Inflamm 2015;2015:569512.
          doi: 10.1155/2015/569512pubmed: 26770019google scholar: lookup
        6. Nishijima CM, Delella FK, Rodrigues CM, Rinaldo D, Lopes-Ferreira MV, da Rocha LR, Vilegas W, Felisbino SL, Hiruma-Lima CA. The Anti-Inflammatory Effects of the Methanolic Extract and Fractions from Davilla elliptica St. Hil. (Dilleniaceae) on Bothrops jararaca Envenomation. Int J Mol Sci 2015 Jun 2;16(6):12454-66.
          doi: 10.3390/ijms160612454pubmed: 26042466google scholar: lookup
        7. Xiang Y, Kogel U, Gebel S, Peck MJ, Peitsch MC, Akmaev VR, Hoeng J. Discovery of Emphysema Relevant Molecular Networks from an A/J Mouse Inhalation Study Using Reverse Engineering and Forward Simulation (REFS™). Gene Regul Syst Bio 2014;8:45-61.
          doi: 10.4137/GRSB.S13140pubmed: 24596455google scholar: lookup
        8. Koivunen AL, Maisi P, Konttinen YT, Prikk K, Sandholm M. Collagenolytic activity and its sensitivity to doxycycline inhibition in tracheal aspirates of horses with chronic obstructive pulmonary disease. Acta Vet Scand 1997;38(1):9-16.
          doi: 10.1186/BF03548503pubmed: 9129342google scholar: lookup